GSK’s anti-BCMA drug Blenrep wins US approval
First anti-BCMA therapy to be approved anywhere in the world
Read More
Author: Lucy Parsons
Second COVID-19 peak in the UK can be avoided with testing and tracing, study finds
Study co-led by UCL and the London School of Hygiene & Tropical Medicine
Read More
AZ’s Fasenra study confirms robust efficacy in eosinophilic asthma
Drug reduced annual rate of asthma exacerbations by 49%
Read More
UCB’s Cimzia bags EU label extension
Drug is first biologic in Europe to be approved with a dose reduction label for axSpA patients
Read More
NICE updates guidance on chronic pain treatments
Draft guidance says some commonly used drug treatments should be avoided
Read More- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
